| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 07/03/2002 | EP1219293A2 Pharmaceutical aerosol compostion |
| 07/03/2002 | EP1218356A1 Quinazoline compounds and pharmaceutical compositions containing them |
| 07/03/2002 | EP1218354A1 Quinazoline derivatives and their use as pharmaceuticals |
| 07/03/2002 | EP1218022A2 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba |
| 07/03/2002 | EP1218013A2 Phospholipid prodrugs of anti-proliferative drugs |
| 07/03/2002 | EP0886517B1 Method for reducing skin oils and grease |
| 07/03/2002 | CN1357038A Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions |
| 07/03/2002 | CN1357002A Compositions for treating inflammatory response |
| 07/03/2002 | CN1356907A Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/03/2002 | CN1356897A Method of treating sleep apnoea |
| 07/03/2002 | CN1356891A Skin cleaning method for eliminating comedones and scales from parts of skin subjected to proliferation of i(candida Alibicans) |
| 07/03/2002 | CN1356867A Texturized cellulosic and lignocellulosic materials and compsns. and composites made thereform |
| 07/02/2002 | US6414156 Efficent, notoxic process of making new key intermediate quaternary ammonium salts and 2-oxazolylalkyl sulfide derivatives and avoids the reaction of a-haloketones with an azide followed by reducing the resulting a-aminoketone |
| 07/02/2002 | US6413980 Nitrogen containing heterobicycles as factor Xa inhibitors |
| 07/02/2002 | US6413525 Methods of exfoliation using N-acetyl glucosamine |
| 06/27/2002 | WO2002050066A2 Pyrazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002050065A2 Pyrazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002049666A2 Mycoplasma hyopneumoniae bacterin vaccine |
| 06/27/2002 | WO2002049659A1 A method to enhance the immune system and used for the prevention and treatment of asthma |
| 06/27/2002 | WO2002049658A1 A method to enhance the immune system and used for the prevention and treatment of infectious diseases |
| 06/27/2002 | WO2002049574A2 Method for curing child's and adolescent myopia using a spiruline preparation |
| 06/27/2002 | WO2002030393A3 Polymeric delivery formulations of leuprolide with improved efficacy |
| 06/27/2002 | WO2002022168A3 Vaccine against streptococcus pneumoniae |
| 06/27/2002 | WO2002022167A3 Vaccine against streptococcus penumoniae |
| 06/27/2002 | WO2002007672A3 A medicinal aerosol formulation |
| 06/27/2002 | WO2001097768A3 Method of making enhanced efficacy antiperspirant actives |
| 06/27/2002 | WO2000056348A9 Inflammatory mediation obtained from atractylodes lancea |
| 06/27/2002 | US20020081336 Parenterally administrable microparticles |
| 06/27/2002 | CA2431743A1 A method to enhance the immune system and used for the prevention and treatment of asthma |
| 06/27/2002 | CA2431740A1 A method to enhance the immune system and used for the prevention and treatment of infectious diseases |
| 06/26/2002 | EP1216705A2 The use of growth factor modulation compounds substituted with three vicinal phosphorus containing radical in the manufacture of a medicament for tissue repair |
| 06/26/2002 | EP1185948A4 Method for screening and producing compound libraries |
| 06/26/2002 | CN1355799A 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 06/26/2002 | CN1355784A Mono-and-disubstituted 2-pyrolyl gamma-aminobutric acids |
| 06/26/2002 | CN1086700C Benzothiophene compounds, intermediates, composition, and methods |
| 06/26/2002 | CN1086589C Vaccines |
| 06/26/2002 | CN1086575C New stable medicinal compositions for generating propellant-free aerosols |
| 06/26/2002 | CN1086569C Dehydration plant |
| 06/25/2002 | US6410780 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments |
| 06/25/2002 | US6410593 Antidandruff compositions |
| 06/20/2002 | WO2002047708A2 Selective cox-2 inhibition from edible plant extracts |
| 06/20/2002 | WO2002047642A1 Hypoallergenic and non-irritant skin care formulations |
| 06/20/2002 | WO2002013766A3 Valproic acid derivatives for the treatment of pain |
| 06/20/2002 | WO2001095870A3 Compositions with low irritancy |
| 06/20/2002 | US20020077482 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 06/20/2002 | US20020077341 C10 carbamoyloxy substituted taxanes |
| 06/20/2002 | US20020076446 Novel medicinal herbal composition for treating liver diseases and HIV |
| 06/19/2002 | EP1214930A1 Hypoallergenic and non-irritant skin care formulations |
| 06/19/2002 | EP1214076A1 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| 06/19/2002 | EP1214052A1 Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
| 06/19/2002 | EP0980354B1 Vitamin d3 analogs with bis c-20 side chains |
| 06/19/2002 | EP0754061B1 New oral pharmaceutical dosage form |
| 06/19/2002 | CN1354656A Compositions and methods for mucosal delivery |
| 06/18/2002 | US6407073 Use of coumarin derivatives for the treatment of digestive tract disorders |
| 06/13/2002 | WO2002046237A2 Humanized antibodies that recognize beta amyloid peptide |
| 06/13/2002 | WO2002045731A1 Activity of extract of piper betle leaves against leishmania |
| 06/13/2002 | WO2002020038A3 Method for down-regulating ige |
| 06/13/2002 | WO2002003998A3 Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| 06/13/2002 | WO2002002054A3 Methods and compositions for the diagnosis of schizophrenia |
| 06/13/2002 | US20020073428 Downloading and transfer of audio or video data from video broadcasts |
| 06/13/2002 | US20020072616 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 06/12/2002 | EP1213291A1 Spiro [1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine for use in the treatment of psychotic and intellectual impairment disorders |
| 06/12/2002 | EP1213020A2 Pharmaceutical compositions having appetite suppressant activity |
| 06/12/2002 | EP1212089A2 Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonists |
| 06/12/2002 | EP1058536B1 Compositions with low irritancy |
| 06/12/2002 | EP1032571B1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 06/12/2002 | EP0768881B1 Anti-hiv triple combination comprising zidovudine, lamivudine and loviride |
| 06/12/2002 | CN1353712A Polymorphs of crystalline (2-benzhydryl-2-azabicyclo [2.2.2] OCT-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as NK-1 receptor antagonists |
| 06/12/2002 | CN1353698A Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives |
| 06/12/2002 | CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds |
| 06/12/2002 | CN1353612A Tanacetum parthenium extract |
| 06/12/2002 | CN1353603A Method of controlling weight gain associated with therapeutic drugs |
| 06/12/2002 | CN1353598A 止汗剂组合物 Antiperspirant composition |
| 06/12/2002 | CN1086189C Ultra-fine microcrystalline cellulose compositions and process for their manufacture |
| 06/06/2002 | WO2002044422A2 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits |
| 06/06/2002 | WO2002044182A1 Condensed purine derivatives as a1 adenosine receptor antagonists |
| 06/06/2002 | WO2002043762A2 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 06/06/2002 | WO2002043739A2 Dermatological formulations containing clindamycin and a zinc-salt |
| 06/06/2002 | WO2002043578A2 Determination of risk and treatment of complications of prematurity |
| 06/06/2002 | US20020068746 Pyrrolo[2,3-d]pyrimidine compounds |
| 06/06/2002 | CA2430298A1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 06/06/2002 | CA2430054A1 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits |
| 06/06/2002 | CA2429615A1 Determination of risk and treatment of complications of prematurity |
| 06/05/2002 | EP1211241A1 Prostaglandin e analogues |
| 06/05/2002 | EP1210942A2 Microparticles |
| 06/05/2002 | EP1210937A2 Device for topical treatment of acne and its method of manufacture |
| 06/05/2002 | EP1210344A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 06/05/2002 | EP1210119A1 Pharmaceutical compositions for oral and topical administration |
| 06/05/2002 | EP1210078A1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 06/05/2002 | EP1121112B1 Stable formoterol concentrate |
| 06/05/2002 | EP0889729B1 Linseed drug |
| 06/05/2002 | EP0884997B1 Compositions containing an antifungal and a sulfur compound |
| 06/05/2002 | EP0741574B1 Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same |
| 06/05/2002 | CN1352644A I-amino triazolo [4,3-alpha] quinazoline -5-ones and/or -5-thiones inhibiting phosphodiesterase IV |
| 06/05/2002 | CN1352640A Mutual prodrugs of amlodipine and atorvastatin |
| 06/05/2002 | CN1352553A Weight loss after pregnancy |
| 06/05/2002 | CN1352552A Treatment of osteoarthritis |
| 06/05/2002 | CN1352549A Methods and devices for providing prolonged drug therapy |
| 06/04/2002 | US6399780 Kinase inhibitors; anticancer agents |
| 06/04/2002 | US6399660 Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis |